Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs

Monday, May 20, 2019

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Apple Inc. (AAPL) and The Goldman Sachs Group, Inc. (GS). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Johnson & Johnson’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry so far this year (+7.4% vs. -1.1%). J&J’s sales and earnings growth is expected to accelerate in the long run, supported by contribution from new drugs like Tremfya and successful label expansion of cancer drugs like Imbruvica and Darzalex and immunology drug, Stelara.

J&J is also making rapid progress with its pipeline and line extensions. It has already gained FDA approval for two new drugs in 2019, Balversa and Spravato. Meanwhile, share buybacks and restructuring initiatives should provide bottom-line support. However, headwinds like biosimilar/generic competition and pricing pressure remain.

(You can read the full research report on Johnson & Johnson here >>>).

Shares of Apple have outperformed the broader S&P 500 index on a year-to-date basis (+19.8% vs. +13.4%). Apple’s services segment, in particular, is expected to grow strongly on solid App Store sales and increasing adoption of Apple Music and Apple Pay.

But there are significant headwinds for Apple. Weak iPhone demand, particularly in China and emerging economies, is a headwind. Further, the company continues to lose share in the smartphone market due to stiff competition from Chinese handset makers. Moreover, the ongoing U.S.-China trade war doesn’t bode well for the company.

(You can read the full research report on Apple here >>>).

Goldman Sachs' shares have outperformed the Zacks Financial - Investment Bank industry so far this year, gaining +18.1% vs +7.8%. Goldman’s first-quarter 2019 results reflected solid financial advisory revenues and lower expenses, partly offset by disappointing performance of Institutional Client Services unit and lower underwriting business. Notably, Goldman has been embroiled in the scandal related to the multibillion-dollar 1Malaysia Development Bhd (1MDB), which is a major concern.

Nevertheless, Goldman’s well-diversified business and focus to capitalize on growth opportunities through strategic moves, along with cost-control efforts, will continue to strengthen the overall business.

(You can read the full research report on Goldman Sachs here >>>).

Other noteworthy reports we are featuring today include Accenture plc (ACN), IBM Corp. (IBM) and Netflix, Inc. (NFLX).

Zacks' Top 10 Stocks for 2019

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?

Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.

See Latest Stocks Today >>

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

J&J (JNJ) to Face Generic Woes in 2019, Recover in 2020

Apple (AAPL) Banks on Services to Counter Weak iPhone Demand

Goldman (GS) Exhibits Cost Control; Legal Issues Linger

Featured Reports

Rising Tourism Aid Hawaiian Electric (HE) Amid Debt Risk

Per the Zacks analyst, rising visitor arrivals boost Hawaii's tourism that bolster Hawaiian Electric's growth.

Accenture (ACN) to Benefit From the Acquisition of Droga5

The Zacks analyst believes that the acquisition of creative agency Droga5 will help Accenture expand its advertising creative business.

Increasing Revenues, Solid Balance Sheet Aid Visa (V)

Per the Zacks analyst, Visa's numerous partnerships and buyouts, shift to digital payments, increasing use of debit and credit cards have driven revenues; its strong balance sheet aids investments.

D.R. Horton (DHI) Banks on Solid Backlog, Gross Margin Soft

Per the Zacks analyst, D.R. Horton is poised to gain from its solid backlog, well-stocked supply of land, lots and homes.

Papa John's (PZZA) Fights Declining Comps With Franchising

The Zacks analyst thinks that Papa John's efforts to strengthen its franchise relations will help the company expand its worldwide presence and thereby revive its declining sales

Adoption of Cloud, Security & Analytics Solutions Aids IBM

Per the Zacks analyst, IBM's blockchain, cloud and ML capabilities, among others, should drive adoption of its solutions.

Robust Content to Aid Netflix (NFLX) Amid Stiff Competition

Per the Zacks analyst, Netflix's robust original movie slate, strong regional content portfolio and subscriber addition is expected to help it steer away competition.

New Upgrades

Strong Aviation Segment Drives General Electric's (GE) Sales

Per the Zacks analyst, solid performance of General Electric's Aviation segment, led by strong demand of GE90 and GE9X engines and higher service revenue will continue to lend momentum to the company.

Solid Loyalty Program to Drive Ulta Beauty's (ULTA) Top Line

Per the Zacks analyst, Ulta Beauty's top line is set to gain from its loyalty program, which will be aided by brand additions, loyalty member maturations and higher penetration of credit card program.

Southern (SO) Buoyed by Federal Loan Guarantee for Vogtle

The Zacks analyst believes that the U.S. federal government's approval of $3.7 billion in loan guarantees for the Vogtle nuclear plant will help Southern Company reduce its financing costs.

New Downgrades

Higher Costs, Lower Phosphate Demand to Hurt Mosaic (MOS)

Per the Zacks analyst, higher costs related to the impact of new tailings dam regulations in Brazil will weigh on Mosaic's margin.

Rising SG&A Expenses Irk Syneos (SYNH) Amid Fierce Rivalry

The Zacks analyst worries about Syneos's rising SG&A expenses which are putting pressure on margins. Also, tough competitive Contract Research Organization market is a worry.

Carnival (CCL) Plagued With High Fuel & Advertising Expenses

The Zacks analyst thinks that increased investments in advertising and TV programming are hurting Carnival's profit margins.

undefined undefined
Netflix, Inc. (NFLX): Free Stock Analysis Report
Johnson & Johnson (JNJ): Free Stock Analysis Report
International Business Machines Corporation (IBM): Free Stock Analysis Report
The Goldman Sachs Group, Inc. (GS): Free Stock Analysis Report
Accenture PLC (ACN): Free Stock Analysis Report
Apple Inc. (AAPL): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.